Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-10

Clinical Trial Update: Vitiligo, New Treatment and Serum s100B [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating a new treatment for generalized vitiligo, with serum s100B, is currently recruiting at South Valley University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: South Valley University | Conditions: Vitiligo, Generalized | Phase 2, Phase 3 | Status: RECRUITING